NCT04963270 2025-02-28A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia GravisHoffmann-La RochePhase 3 Terminated188 enrolled 40 charts